Current treatment status-Currently treated-Dual therapy Posts on Medivizor
Navigation Menu

Current treatment status-Currently treated-Dual therapy Posts on Medivizor

Are low-dose glucocorticoids safe and effective in combination with methotrexate and hydroxychloroquine in early rheumatoid arthritis?

Are low-dose glucocorticoids safe and effective in combination with methotrexate and hydroxychloroquine in early rheumatoid arthritis?

Posted by on Aug 9, 2020 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated the use of low dose (LD) glucocorticoids (GC) combined with methotrexate (MTX; Otrexup) and hydroxychloroquine (HCQ; Plaquenil).in early rheumatoid arthritis (RA). They found that LD-GCs improved disease activity (DA) combined with MTX and HCQ in these patients. Some background...

Read More

Examining the link between rituximab treatment, immune cell response and disease activity?

Examining the link between rituximab treatment, immune cell response and disease activity?

Posted by on Dec 7, 2016 in Rheumatoid Arthritis | 0 comments

In a nutshell This study looked at the effect of rituximab (Rituxan) and levels of immune cells in patients with rheumatoid arthritis (RA).The authors concluded that certain immune cells are linked to disease activity in patients treated with rituximab. Measuring the levels of these cells could be used to determine if rituximab re-treatment is...

Read More

Does reducing etanercept maintain remission in early rheumatoid arthritis?

Does reducing etanercept maintain remission in early rheumatoid arthritis?

Posted by on Mar 28, 2016 in Rheumatoid Arthritis | 0 comments

In a nutshell This study assessed the effects of reducing and withdrawing treatment in rheumatoid arthritis (RA) patients who had achieved remission using etanercept (Enbrel) plus methotrexate (Trexall). The results showed that etanercept and methotrexate (MTX) combined led to better disease control than MTX alone, or a placebo (a substance...

Read More

Do certain drugs increase the risk of cervical cancer in women with rheumatoid arthritis?

Posted by on Feb 28, 2016 in Rheumatoid Arthritis | 0 comments

In a nutshell This study examined the risk of cervical cancer in women with rheumatoid arthritis (RA) treated with tumor necrosis factor (TNF)-inhibitors. The study concluded that women with RA treated with TNF-inhibitors are at increased risk of cervical cancer.  Some background RA is a chronic autoimmune disease (when the immune system...

Read More

Is golimumab safe and effective in rheumatoid arthritis patients who have previously taken anti-TNF therapy?

Is golimumab safe and effective in rheumatoid arthritis patients who have previously taken anti-TNF therapy?

Posted by on Jun 21, 2015 in Rheumatoid Arthritis | 0 comments

In a nutshell This study examined whether golimumab (Simponi) is safe and effective in rheumatoid arthritis patients who have previously used anti-tumor necrosis factor therapy. Some background Anti-tumor necrosis factor (TNF) therapy (Humira, Enbrel, Remicade and Cimzia) is used to treat patients who have a severe form of rheumatoid arthritis...

Read More

Non-steroidal anti-inflammatory drugs in rheumatic patients: the impact on the gastrointestinal tract

Posted by on Jun 7, 2015 in Rheumatoid Arthritis | 0 comments

In a nutshell This study examined the frequency of gastrointestinal (digestive tract) events in at-risk rheumatic patients using non-steroidal anti-inflammatory drugs. Some background Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (Advil) are used to relieve pain in patients with rheumatic diseases. However, they can also cause...

Read More

Is subcutaneous injection of Actemra safe and effective in rheumatoid arthritis patients?

Is subcutaneous injection of Actemra safe and effective in rheumatoid arthritis patients?

Posted by on May 18, 2015 in Rheumatoid Arthritis | 0 comments

In a nutshell This study examined the safety and effectiveness of switching from intravenous tocilizumab (Actemra) to subcutaneous. Some background Tocilizumab is a drug which prevents the immune system from attacking the joints in rheumatoid arthritis patients. It is given intravenously (injected into a vein by a healthcare...

Read More